Unlicensed and off label drug use in neonates Commentary
Open Access
- 1 March 1999
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 80 (2), F142-F145
- https://doi.org/10.1136/fn.80.2.f142
Abstract
AIM To determine the extent of use of drugs that are either not licensed (unlicensed), or are outside the terms of their product licence (off label) in a neonatal intensive care unit. METHODS A prospective study was conducted over 13 weeks. RESULTS 455 prescription episodes were administered to 70 babies. 63 (90%) patients were given a drug that was either unlicensed or used in an off label way. 54.7% prescription episodes were off label, many for more than one reason, and 9.9% (45) were unlicensed; 35.4% (161) prescription episodes were licensed. CONCLUSION The use of unlicensed and off label drugs in neonatal intensive care seems to be far greater than other paediatric settings. This highlights the difficulties faced by those trying to ensure safe and effective prescribing for neonates. Urgent action is required to resolve this situation.Keywords
This publication has 6 references indexed in Scilit:
- Unlicensed and off label drug use in paediatric wards: prospective studyBMJ, 1998
- Group B streptococcal infections.1997
- Pharmacokinetics and renal function in preterm infantsActa Paediatrica, 1996
- Use of "off-label" and unlicensed drugs in paediatric intensive care unitThe Lancet, 1996
- Prevention of vitamin K deficiency in infancy by weekly administration of vitamin KActa Paediatrica, 1993
- Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.Archives of Disease in Childhood, 1992